January, 2021

AFR Reports of Dispute Between R&D Entity and R&D Advisor for Liability Over Reversed R&D Claims

January 25th, 2021

In early January 2021, the AFR published a story in respect of an Australian R&D Entity taking legal action against a large professional advisory firm in respect of allegations that its tax advice was below industry standards, not fit for purpose, and not undertaken with due care or diligence. The case specifically relates to R&D Claims the Australian R&D Entity made in the in the FY14 and FY15 periods which were subject to reviews by the ATO and AusIndustry, leading […]

Read More

Australian Companies Increasing Project Investment Based on More Favorable R&D Tax Environment

January 18th, 2021

The Government’s R&D Tax Incentive budget announcement on 6 October 2020 largely backed away from previously proposed and widely condemned retrospective cuts to the programme, and contained some additional R&D Tax benefits not previously anticipated, which are to apply from FY22. The SMH has this week reported that Australian companies have made substantial increases in their R&D Budgets as a direct result of the government’s R&D Tax Measures passed late last year. Cochlear and Resmed are quoted by the SMH […]

Read More

Monadelphous Successfully Challenges R&D Tax Dispute Following Conclusion of Internal Review

January 11th, 2021

One of the most high profile R&D Tax disputes has been that of engineering contractor Monadelphous. In August 2019 Monadelphous recognised a $7 Million provision relating to repayment of R&D Claims for the FY15 and FY16 periods. The provision indicated that the underlying disputed R&D Activities may have R&D Expenditure of around $70 to $80 Million, and followed a previous announcement in May 2019 that the company had received notices of amended assessments from the ATO relating to findings by […]

Read More

Categories

Archives

    Email this job